BIOMARIN PHARMACEUTICAL INCBIOMARIN PHARMACEUTICAL INCBIOMARIN PHARMACEUTICAL INC

BIOMARIN PHARMACEUTICAL INC

No trades
See on Supercharts

Price target

89.180.000.00%
The 26 analysts offering 1 year price forecasts for BMRN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 30 analysts giving stock ratings to BMRN in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


BMRN EPS for the last quarter is 0.49 EUR despite the estimation of 0.48 EUR. In the next quarter EPS is expected to reach 0.51 EUR. Track more of BIOMARIN PHARMACEUTICAL INC financials and stay on top of what is up with the company.
In the next quarter BIOMARIN PHARMACEUTICAL INC revenue is expected to reach ‪654.77 M‬ EUR. Check out BIOMARIN PHARMACEUTICAL INC revenue and earnings and make informed decisions.
According to analysts, BMRN price target is 89.18 EUR with a max estimate of 117.22 EUR and a min estimate of 60.00 EUR. Check if this forecast comes true in a year, meanwhile watch BIOMARIN PHARMACEUTICAL INC stock price chart and keep track of the current situation with BMRN news and stock market news.
We've gathered opinions of 30 analysts rating BMRN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.